KALEY PRATHER: Open Payments
NPI 1023479516 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 85 payments from 15 companies in 2025. Trend: 2023 $1,296 · 2024 $1,585 · 2025 $1,573
Food & beverage: $1,573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $415 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $361 |
| Ipsen Biopharmaceuticals, Inc | 5 | $203 |
| PFIZER INC. | 9 | $144 |
| QOL Medical, LLC | 6 | $140 |
| Janssen Biotech, Inc. | 3 | $49 |
| Biocon Biologics Inc | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
Products named: XIFAXAN, IQIRVO, RINVOQ, Sucraid, VELSIPITY, LINZESS, TREMFYA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
